Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

67 trials with published results (28%)

Research Maturity

149 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

8.0%

19 terminated out of 237 trials

Success Rate

88.7%

+2.1% vs benchmark

Late-Stage Pipeline

9%

22 trials in Phase 3/4

Results Transparency

45%

67 of 149 completed with results

Key Signals

67 with results89% success19 terminated

Data Visualizations

Phase Distribution

206Total
Not Applicable (47)
Early P 1 (1)
P 1 (42)
P 2 (94)
P 3 (15)
P 4 (7)

Trial Status

Completed149
Unknown27
Recruiting19
Terminated19
Withdrawn11
Active Not Recruiting8

Trial Success Rate

88.7%

Benchmark: 86.6%

Based on 149 completed trials

Clinical Trials (237)

Showing 20 of 20 trials
NCT03884075Phase 2RecruitingPrimary

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

NCT04822181Phase 3Active Not RecruitingPrimary

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

NCT06297434Phase 2CompletedPrimary

Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH

NCT04302051Withdrawn

Assessment of Fatty Liver With Thermo-acoustic Device

NCT06138821Not ApplicableRecruiting

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

NCT05330923Recruiting

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

NCT04595474Active Not Recruiting

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

NCT06819917Recruiting

Identification of Liver Fibrosis Biomarkers

NCT04801849Phase 2Completed

Vitamin E Dosing Study

NCT02815891Completed

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT07580482Not ApplicableCompleted

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

NCT05623150Recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05720663RecruitingPrimary

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

NCT07481734Phase 2Recruiting

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

NCT06465186Phase 2Active Not Recruiting

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT05728697Recruiting

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

NCT05526144Phase 2RecruitingPrimary

Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

NCT06716905Phase 1CompletedPrimary

Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants

NCT04690972Recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

NCT04666402Recruiting

Integrated Diagnostics for Early Diagnosis of Liver Disease

Scroll to load more

Research Network

Activity Timeline